A previous study reported that METTL3 was highly expressed in the metastatic tissues of CRC and inhibited the mRNA degradation of SRY-box transcription factor 2 (SOX2) by specifically interacting with m6A reader IGF2BP2 [117]. Here, SOX2 is linked to colorectal carcinoma.